HOME >> BIOLOGY >> NEWS
EPA Should Redirect Some Research on Toxic Airborne Particles

WASHINGTON -- As the Environmental Protection Agency (EPA) tightens standards for airborne particulates, it should redirect some research and maintain an integrated study program ensuring that the most serious public health risks posed by the particles are addressed, says a new report by a committee of the National Research Council. To that end, EPA should devote more funds to studying the types of particles most likely to be harmful to human health, the ways the particles cause damage, and the levels of exposure people actually receive.

"Recent studies have consistently shown that airborne particles are somehow associated with adverse health effects, especially for people with heart and lung ailments," said committee chair Jonathan Samet, professor and chair, department of epidemiology, Johns Hopkins University School of Hygiene and Public Health, Baltimore. "But as the new standards begin to take effect, further research must be done to determine precisely which particles pose the greatest health risks, and how. Gathering this information should be of the highest priority. The results will greatly increase the likelihood that money spent on regulating and controlling particulates will fully protect public health."

EPA recently set stricter standards for particulate matter -- a broad class of materials that originate from industrial manufacturing processes, forest fires, automobile exhaust, fossil fuel combustion, wind erosion, and a variety of other sources. The standards were changed after several epidemiological studies found associations between exposure to the particles and serious health consequences, including the exacerbation of asthma and other respiratory tract diseases -- which in some cases were leading to premature deaths. The new standards, set last July, for the first time target particulates smaller than 2.5 microns in diameter. When inhaled, these tiny particles are more l
'"/>

Contact: Molly Galvin, Kristen Nye
news@nas.edu
202-334-2138
The National Academies
1-Apr-1998


Page: 1 2 3 4

Related biology news :

1. Should Roundup Ready soybeans be managed differently than conventional soybeans?
2. Should publicly funded research be free and available to the public?
3. Fine Toothed Combs, Not Chemicals, Should Be Used To Treat Head Lice
4. Iron Supplemented Formula Milk Should Be Free For Inner City Children Into Their Second Year Of Life
5. Should Great Apes Be Given Legal Rights?
6. Penn Researchers Prove "Short-Cut" Function Of Myelin Sheath Channel: BetterUnderstanding Of Myelin Should Lead To Therapies For Neuropathies
7. Adults Need To Increase Intake Of Folate; Some Women Should Take More
8. Drivers Should Pay More Of Environmental Costs, Report Says
9. Lactose-Intolerant People Should Drink More Milk, Expert Says
10. Infants, Toddlers Should Not Restrict Fat Intake, Experts Say
11. Bee Sting Treatment Should Emphasize Speed, Not Method Of Removal

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: EPA Should Redirect Some Research Toxic Airborne Particles

(Date:12/19/2014)... and Markets ( http://www.researchandmarkets.com/research/8kmfcn/iphone_5s ) has announced ... - Apple/AuthenTec TMDR92 & Sapphire - Technology Report" ... http://photos.prnewswire.com/prnh/20130307/600769 Following the acquisition of AuthenTec ... with the iPhone 5S. It is currently the only ...
(Date:12/19/2014)... Dec. 18, 2014   LaunchKey , the first decentralized ... and Internet of Things era, today announced the close ... round was led by Metamorphic Ventures with participation from ... VegasTechFund, and others.  LaunchKey has raised $4 million to ...
(Date:12/17/2014)... YORK , Dec. 15, 2014  HITLAB SM ... (GCP) audit to confirm its adherence to current U.S. ... HITLAB to conduct regulated smart device and smart phone ... and research quality. "HITLAB is determined to ...
Breaking Biology News(10 mins):iPhone 5S Fingerprint Sensor - Apple/AuthenTec TMDR92 & Sapphire - Technology Report 2LaunchKey Raises $3 Million in Additional Funding Led by Metamorphic Ventures 2LaunchKey Raises $3 Million in Additional Funding Led by Metamorphic Ventures 3HITLAB Completes GCP Audit for FDA Smart Device & App Compliance 2
(Date:1/22/2015)... DIEGO , Jan. 22, 2015   Cypher ... and Sequenom, Inc. (NASDAQ: SQNM ), ... development agreement for next generation noninvasive prenatal tests ... genome interpretation technology, called Mantis™, to advance analysis ...
(Date:1/22/2015)... 2015   GenoSpace , a precision medicine software company that ... broad use of genomic, imaging and other biomedical data in ... Michelle Munson , CEO of Aspera, an IBM Company, to ... http://photos.prnewswire.com/prnh/20150122/170713 "We are pleased to ...
(Date:12/25/2014)... 2014 The report “Service Quality Management ... & Provider Type - Global Advancements, Worldwide Forecasts & ... in-depth analysis and forecasting of revenues. , Browse ... pages and in-depth TOC on “Service Quality Management (SQM) ...
(Date:12/24/2014)... YORK , Dec. 24, 2014 PlasmaTech Biopharmaceuticals, Inc. ... critical areas, announced the closing of an underwritten public offering ... up to an aggregate 3,500,000 shares of common stock, at ... warrant.  The warrants have a per share exercise price of ...
Breaking Biology Technology:Cypher Genomics and Sequenom Announce Development Agreement 2Cypher Genomics and Sequenom Announce Development Agreement 3Cypher Genomics and Sequenom Announce Development Agreement 4GenoSpace Expands Board with Appointment of Michelle Munson 2Service Quality Management Market worth $2.1 Billion & Telco Customer Experience Management Market worth $2.3 Billion by 2019 – New Report by MarketsandMarkets 2Service Quality Management Market worth $2.1 Billion & Telco Customer Experience Management Market worth $2.3 Billion by 2019 – New Report by MarketsandMarkets 3Service Quality Management Market worth $2.1 Billion & Telco Customer Experience Management Market worth $2.3 Billion by 2019 – New Report by MarketsandMarkets 4PlasmaTech Biopharmaceuticals, Inc. Announces Closing of Public Offering 2PlasmaTech Biopharmaceuticals, Inc. Announces Closing of Public Offering 3
Cached News: